Furthermore, as this was an exploratory study, we specifically targeted FECD patients with TCF4 TNR expansion > 50 repeats to focus on subjects with well-characterized genetic backgrounds. This evidence concerns the gene TCF4 and Fuchs endothelial corneal dystrophy.